Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone versus placebo for functional abdominal pain in children
IRCT20140304016844N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional abdominal pain (FAP) comparing Buspirone with Placebo (2 arms). Primary endpoint: Pain relief. Started Jan 2018; status: completed.
02
Drugs
buspirone
03
Conditions
functional abdominal pain (FAP)
Beyond the preview
Go deeper on IRCT20140304016844N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140304016844N3.